𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Structural and functional analysis of a novel mutation of CYP21B in a heterozygote carrier of 21-hydroxylase deficiency

✍ Scribed by Jörg Bojunga; Christoph Welsch; Iris Antes; Mario Albrecht; Thomas Lengauer; Stefan Zeuzem

Publisher
Springer
Year
2005
Tongue
English
Weight
459 KB
Volume
117
Category
Article
ISSN
0340-6717

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two novel CYP21A2 missense mutations in
Two novel CYP21A2 missense mutations in Italian patients with 21-hydroxylase deficiency: Identification and functional characterisation
✍ Paola Concolino; Francesca Vendittelli; Enrica Mello; Cristiana Carelli Alinovi; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

## Abstract Steroid 21‐hydroxylase deficiency is present in more than 90% of patients with congenital adrenal hyperplasia (CAH), an inherited metabolic disorder of adrenal steroidogenesis. Impaired enzymatic activity leads to the accumulation of metabolic intermediates (progesterone and 17‐hydroxyp

Who is a carrier? Detection of unsuspect
Who is a carrier? Detection of unsuspected mutations in 21-hydroxylase deficiency
✍ Siegel Witchel, Selma ;Lee, Peter A. ;Trucco, Massimo 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 1 views

Congenital adrenal hyperplasia due to 21hydroxylase deficiency is a common autosomal-recessive disorder. During our routine genotyping of affected individuals and their relatives using allele-specific oligonucleotide hybridization and single-strand conformational polymorphism analysis, we identified

A novel frameshift mutation (141delT) in
A novel frameshift mutation (141delT) in exon 1 of the 21-hydroxylase gene (CYP21) in a patient with the salt wasting form of congenital adrenal hyperplasia
✍ Nils Krone; Andreas Braun; Adelbert Anton Roscher; Hans Peter Schwarz 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB 👁 2 views

Congenital adrenal hyperplasia (CAH) is a common autosomal recessive disease with a wide range of clinical manifestation. In 90-95% of the cases it is caused by 21-hydroxylase deficiency (OMIM #201910) due to mutations of the CYP21 gene (GDB Accession #M12792). In most cases the CYP21-inactivating p